Sabina Chiaretti

9PUBLICATIONS
34CO-AUTHORS
Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyIntensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 21, 2024
Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies.

Francesco Malfona, Anna Maria Testi, Sabina Chiaretti

|Dec 21, 2023
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.

Robin Foà, Renato Bassan, Loredana Elia

|Sep 13, 2023
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.

Darina Ocadlikova, Federico Lussana, Nicola Fracchiolla

|Jul 15, 2023
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase.

Deborah Cardinali, Marco Beldinanzi, Michela Ansuinelli

|Nov 06, 2022
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.

Michelina Dargenio, Massimiliano Bonifacio, Sabina Chiaretti

|Nov 05, 2020
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia.

Monia Lunghi, Andrea Patriarca, Mariangela Greco

Pageof 2

Frequent Collaborators

4 joint publications

Robin Foà

2 joint publications

Monica Messina

2 joint publications

Irene Della Starza

2 joint publications

Anna Maria Testi